Used in research and development for targeting nerve growth factor (NGF) pathways, this antibody helps in studying chronic pain mechanisms, particularly in conditions like osteoarthritis and neuropathic pain. It serves as a reference tool for characterizing anti-NGF therapeutics and evaluating binding specificity and potency in immunoassays. Its high selectivity makes it valuable in preclinical studies to assess the efficacy and safety of novel pain treatments. Additionally, it supports quality control in biosimilar development and aids in understanding NGF-related signaling in neurodegenerative and inflammatory diseases.